CAMP4 Therapeutics Corporation (CAMP)
NASDAQ
Market Cap
$147.38M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
584 of 960
Rank in Industry
317 of 550
Largest Insider Buys in Sector
CAMP Stock Price History Chart
CAMP Stock Performance
About CAMP4 Therapeutics Corporation
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.
Insider Activity of CAMP4 Therapeutics Corporation
Over the last 12 months, insiders at CAMP4 Therapeutics Corporation have bought $0 and sold $7,176 worth of CAMP4 Therapeutics Corporation stock.
On average, over the past 5 years, insiders at CAMP4 Therapeutics Corporation have bought $2.56M and sold $153,588 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 25,000 shares for transaction amount of $112,970 was made by Cummins Wes (director) on 2023‑01‑27.
List of Insider Buy and Sell Transactions, CAMP4 Therapeutics Corporation
| 2024-06-05 | Sale | director | 8,640 0.5356% | $0.83 | $7,176 | +715.14% | ||
| 2023-01-27 | director | 25,000 0.069% | $4.52 | $112,970 | -80.57% | |||
| 2023-01-03 | director | 20,000 0.0546% | $4.43 | $88,610 | -77.06% | |||
| 2022-12-30 | director | 30,000 0.0831% | $4.48 | $134,442 | -76.56% | |||
| 2022-12-29 | director | 25,000 0.0661% | $4.35 | $108,655 | -76.70% | |||
| 2022-12-28 | director | 25,000 0.0678% | $3.95 | $98,790 | -73.70% | |||
| 2022-12-27 | director | 40,000 0.1117% | $4.00 | $160,188 | -73.30% | |||
| 2022-12-23 | director | 25,000 0.0694% | $4.17 | $104,340 | -73.92% | |||
| 2022-11-10 | director | 43,600 0.1195% | $3.37 | $146,880 | -41.12% | |||
| 2022-11-09 | director | 63,500 0.1727% | $3.04 | $192,786 | -34.53% | |||
| 2022-10-14 | director | 75,000 0.2062% | $3.25 | $243,593 | -9.23% | |||
| 2022-10-14 | President & CEO | 2,000 0.0057% | $3.36 | $6,719 | -9.23% | |||
| 2022-10-13 | director | 75,000 0.2065% | $3.26 | $244,710 | -6.44% | |||
| 2022-10-12 | director | 60,000 0.1659% | $3.38 | $202,680 | -8.63% | |||
| 2022-10-11 | director | 50,000 0.1374% | $3.56 | $177,900 | -13.48% | |||
| 2022-10-10 | director | 50,000 0.1387% | $3.95 | $197,705 | -21.17% | |||
| 2022-10-10 | President & CEO | 2,000 0.0055% | $3.95 | $7,898 | -21.17% | |||
| 2022-10-07 | director | 100,000 0.2767% | $4.04 | $404,430 | -22.26% | |||
| 2022-09-30 | director | 84,300 0.2356% | $3.90 | $328,854 | -16.80% | |||
| 2022-09-28 | 102,500 0.2822% | $4.39 | $450,334 | -26.88% |
Insider Historical Profitability
20.49%
| Cummins Wes | director | 3424059 16.9835% | $7.31 | 21 | 0 | <0.0001% |
| B. Riley Asset Management, LLC | 2229159 11.0567% | $7.31 | 6 | 0 | <0.0001% | |
| Burdiek Michael J | President & CEO | 615020 3.0505% | $7.31 | 11 | 35 | +72.01% |
| GARDNER JEFFERY R | President & CEO | 487971 2.4204% | $7.31 | 21 | 0 | <0.0001% |
| GOLD RICHARD B | director | 385439 1.9118% | $7.31 | 47 | 12 | +40.79% |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.